post-cal model adjust modestli lower estim
reflect on-going pressur segment
updat model follow monday morn releas
fiscal fourth-quart earn initi guidanc fiscal recal compani
exceed target cent quarter given much lower effect tax rate
oper pharmaceut segment outperform expect medic
under-perform cordi summar model chang
decreas fiscal adjust ep target essenti flat
fiscal midpoint compani initi guidanc addit
decreas fiscal ep estim assum
price stabil return pharma distribut accret patient recoveri
cardin commentari result exactli inspir guidanc
larg consist last quarter contain major surpris result drug
distribut investor breath sigh relief pattern defer price
increas biopharma industri present larg enough trigger anoth
round estim cut fiscal mark third consecut year littl
earn growth cardin manag work within oper
segment within medic cordi continu miss earn target make critic
patient recoveri integr goe smoothli appear downward
pressur margin within core medic suppli distribut busi well
within near-term pressur buy-sid sell-sid
busi longer term econom model may need reset given
uncertainti partial beyond manag control maintain market
perform rate despit stock trade trough valuat
return equiti ttm
one largest healthcar distributor unit state canada strong market
share posit pharmaceut medic product distribut market cardin one three largest
player pharmaceut distribut market signific distributor medic consum suppli
hospit physician offic altern care site
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
pharmaceut segment pharmaceut segment revenu impress quarter
estim oper incom prior year ebit margin busi match
target come year increas revenu target billion larger
base lower ebit target million translat profit declin compar prior
declin target impli margin compress basi point assum basi point
adjust fine tune consid size busi found manag commentari strike
need perhap alter econom model drug distribut re-set success accomplish
industri year ago probabl succeed also highlight degre uncertainti moment
might new model look like manufactur pharmaci reset econom contract
renegoti new model project stabl margin incom growth fiscal convict low
assumpt believ difficult assum pharmaceut segment growth busi
clariti around new model
medic segment medic segment miss target fiscal fourth quarter million revenu
million incom bulk miss driven cordi write-off also prompt billion non-cash write-
also sound like on-going pressur core medic suppli distribut busi revis
model leav revenu target medic unchang billion lower incom
target million million lower base new estim assum ebit margin
basi point last year unlik pharmaceut segment pressur medic appear fixabl
manag larg contain cordi thu comfort outlook medic although
would prefer see transpar organ trend busi back contribut
patient recoveri asset believ busi slightli fiscal organ basi
note lower fiscal adjust ep estim model top-lin growth
unchang given offset segment perform past quarter new segment assumpt note
consolid basi assum basi point ebit margin compress compar basi point
previous assum tax rate compar previous
fiscal assum busi normal produc ep growth revenu growth basi
point margin improv estim ep previous
valuat stock thought
monday close trade time updat calendar ep estim four
turn three-year averag slightli peer group averag maintain
market perform rate despit stock trough multipl given lack convict compani
return consist ep growth come year updat model segment assumpt follow exhibit
good gross oper interest expens pre-tax incom tax net incom excl nonrecur item net earn attribut non-controlling incom cardin excl nonrecur excl tax item net net incom includ nonrec discontinu operationsnet incom includ nonrec discontinu ep excl non-recurring item amort begin fy excl non-recurring item includ incl nonrec item amort excl non-recurring item amort beg averag share outstand analysi gross incom incom rate total incom incom excl non-recurring includ excl non-recurring amort beg fy share blair compani estimatesourc compani report william blair compani llc estim william blair
y/i metro growthorgan y/i growth profit million adjust amort begin fy y/i segment total oper y/i patient y/i growth profit million adjust amort begin fy y/i segment import disclosur
